Loading…
Loading…
The heavy selling pressure might have exhausted for Custom Truck One Source (CTOS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
LCUT, CURI, OSCR, CTOS and CHYM have been added to the Zacks Rank #1 (Strong Buy) List on September 2, 2026.
Bank of America Corp DE lowered its stake in shares of Custom Truck One Source, Inc. (NYSE: CTOS) by 19.2% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,195,836 shares of the company's stock after selling 284,294 shares
Here is how Custom Truck One Source, Inc. (CTOS) and Dorman Products (DORM) have performed compared to their sector so far this year.
The mean of analysts' price targets for Custom Truck One Source (CTOS) points to a 25.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Capstone Therapeutics (NASDAQ: CAPS - Get Free Report) and Custom Truck One Source (NYSE: CTOS - Get Free Report) are both industrials companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends. Profitability This table compares Capstone Therapeutics
Breakout candidates SGC, AMCX and CTOS are trading near 52-week highs after passing technical screens. See why they could gain in August.
Micron, BrightSpring Health and Custom Truck One Source combine strong profitability with earnings growth. See why they stand out in August.